SSD114 HCI is a novel, potent and selective GABAB receptor positive allosteric modulator (PAM).

Vigabatrin hydrochloride (γ-Vinyl-GABA; Sabril) is an oral and structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transaminase.

CTP354, formerly known as C-21191, a novel deuterated subtype-selective GABA(A) modulator. CTP may be potentially useful for treatment of neuropathic pain, spasticity and anxiety disorders.

Tiagabine (NO329; NNC-050328; NO 329; NNC-05-0328; NO-05-0328; trade name Gabitril) is a selective and potent GABA (gamma-aminobutyric acid) reuptake inhibitor with anti-convulsive activity.

Ergoloid Mesylates is a novel and potent dihydrogenated ergot alkaloids

Flumazenil (Flumazepil, Anexate, Romazicon, Lanexat; Ro-15-1788; Ro-15 1788) is a specific and competitive GABAA receptor antagonist that has been used for the treatment of benzodiazepine overdoses.

Nefiracetam (DZL-221; DM9384; DZL221; DM 9384; Translon) is a potent GABAergic, cholinergic, and monoaminergic neuronal system enhancer for Ro 5-4864-induced convulsions.

rac-BHFF is a novel and potent GABAB receptor agonist

Etomidate (Amidate, Ethomidate, Hypnomidate, R-26490, R26490, Radenarkon), discovered at Janssen Pharmaceutica in 1964, is a GABAA receptor agonist that has been approved for use as a short-acting anaesthetic drug or sedative.

Gaboxadol ( Lu-02030, THIP, OV-101; Lu-02-030; MK-0928) is a potent GABA agonist.